US equities |
META $624.66 ▼-0.94% TSLA $404.53 ▲+3.30% MU $924.65 ▲+2.32% NVDA $217.62 ▲+0.75% SPCX $149.77 ▲+1.95% AMD $555.33 ▲+4.53% SNDK $1,292.63 ▲+2.95% INTC $93.07 ▲+2.87%
FinancialContent

Exagen Inc. - Common Stock (NQ:XGN)

7.760 +0.290 (+3.88%)
Delayed Quote Updated: 11:14 AM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
BTIG Maintains Buy Rating for Exagen: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Exagen Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday ↗
With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
Record AVISE® CTD Volume in 2022 
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Earnings Preview ↗
 
Via Benzinga
News headline image
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming March Conferences
From Exagen Inc.
Via GlobeNewswire
News headline image
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments ↗
Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available... 
Via Benzinga
News headline image
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗
Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket ↗
Gainers VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion). 
Via Benzinga
News headline image
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Peering Into Exagen's Recent Short Interest ↗
Exagen's (NASDAQ:XGN) short percent of float has fallen 34.48% since its last report. The company recently reported that it has 20 thousand shares sold short, which is 0.19% of all regular shares that... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
News headline image
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
News headline image
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90% ↗
Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in... 
Via Benzinga
News headline image
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
News headline image
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
News headline image
Exagen Inc. Reports Third Quarter 2022 Results
Medicare Reimbursement Returns 
From Exagen Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 14, 2022 ↗
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
News headline image
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
From Exagen Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 101 companies made new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >